Andrew Bingham

Andrew Bingham is an immunology scientist at a biotechnology development firm in Louisville, Kentucky. After training in academic immunology laboratories, he moved into commercial drug development, where he connects early bench assays with therapeutic pipelines. Bingham investigates immune signaling pathways and optimizes antibody screening protocols. His laboratory research centers on validating cellular assays to measure immune cell responses, helping project teams assess prospective drug candidates before they advance toward formal clinical evaluation.